Signaturefd, LLC Seres Therapeutics, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	BUY	$2.33 - $5.07 $6,969 - $15,164	2,991 New	2,991 $7,000
Q1 2023 Apr 28, 2023	BUY	$4.95 - $6.09 $1,678 - $2,064	339 New	339 $1,000
Q2 2022 Aug 10, 2022	SELL	$2.7 - $7.62 $882 - $2,491	-327 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$6.3 - $8.84 $1,600 - $2,245	254 Added 347.95%	327 $2,000
Q4 2021 Jan 25, 2022	BUY	$6.02 - $11.43 $439 - $834	73 New	73 $1,000
Q1 2021 Apr 30, 2021	SELL	$17.66 - $28.92 $582 - $954	-33 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$23.25 - $37.73 $767 - $1,245	33 New	33 $1,000

41M

304K

471K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $104M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.